Journal of Medicinal Chemistry · 2009 · 62 citations · 27 references
MedicineInfectious DiseasesPharmacologyAntimicrobial PharmacologyDrug DesignDrug DiscoveryAntibacterial AgentsAntibacterial PharmacologyEnzyme InhibitionNovel Antibacterial AgentsNovel Antibacterial Drug Discovery
LcrF, a multiple adaptational response (MAR) transcription factor, regulates virulence in Yersinia pestis and Yersinia pseudotuberculosis. In a search for small molecule inhibitors of LcrF, an acrylic amide series of N-hydroxybenzimidazoles was synthesized and the SAR (structure-activity relationship) was examined. Selected test compounds demonstrated inhibitory activity in a primary cell-free LcrF-DNA binding assay as well as in a secondary whole cell assay (type III secretion system dependent Y. pseudotuberculosis cytotoxicity assay). The inhibitors exhibited no measurable antibacterial activity in vitro, confirming that they do not target bacterial growth. These results demonstrate that N-hydroxybenzimidazole inhibitors, exemplified by 14, 22, and 36, are effective antivirulence agents and have the potential to prevent infections caused by Yersinia spp.
27
Multiple Antimicrobial Resistance in Plague: An Emerging Public Health Risk
Timothy J. Welch, W. Florian Fricke, Patrick F. McDermott et al. · PLoS ONE · 2007 · 400 citations · Full text